help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narahara, H.
Right arrow Articles by Miyakawa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narahara, H.
Right arrow Articles by Miyakawa, I.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 12 6029-6033
Copyright © 2003 by The Endocrine Society


Other Original Article

Platelet-Activating Factor Inhibits the Secretion of Platelet-Activating Factor Acetylhydrolase by Human Decidual Macrophages

Hisashi Narahara, Yasushi Kawano, Kaei Nasu, Jun Yoshimatsu, John M. Johnston and Isao Miyakawa

Department of Obstetrics and Gynecology (H.N., Y.K., K.N., J.Y., I.M.), Oita Medical University, Hasama, Oita 879-5593, Japan; and Departments of Biochemistry and Obstetrics-Gynecology (J.M.J.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9038

Address all correspondence and requests for reprints to: Hisashi Narahara, M.D., Department of Obstetrics and Gynecology, Oita Medical University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan. E-mail: naraharh{at}oita-med.ac.jp.

To clarify the role of platelet-activating factor (PAF) in parturition, the effects of PAF on the secretion of PAF-acetylhydrolase (PAF-AH), a PAF-inactivating enzyme, by decidual macrophage populations were examined. The cells were isolated from human decidual tissue by enzymatic digestion, Ficoll-Paque centrifugation, or flow cytometric sorting. The nonhydrolyzable agonist of PAF, carbamyl-PAF (C-PAF), inhibited the secretion of PAF-AH by either decidual cells or flow cytometrically purified decidual macrophages. A specific PAF receptor antagonist, WEB 2086, blocked the C-PAF-induced inhibition. Lyso-PAF, a metabolite of PAF, had no effect on the enzyme secretion. An intracellular calcium channel blocker, bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetra(acetoxymethyl)-ester, partially blocked the inhibition by C-PAF, whereas extracellular calcium channel blockers, nifedipine and verapamil, were without effect. The inhibitory effect of C-PAF was also partially blocked by protein kinase C (PKC) inhibitors, sphingosine and H-7. A PKC activator, 12-O-tetradecanoylphobol 13-acetate, decreased the secretion of PAF-AH. The decrease was abolished by the addition of sphingosine and H-7. It is suggested that PAF inhibits the PAF-AH secretion by decidual macrophages and that the inhibitory action is mediated by a signal transduction mechanism involving intracellular calcium and PKC.

This work was supported, in part, by a Grant-in-Aid for Scientific Research (13671732) from the Ministry of Education, Science, and Culture of Japan.

Abbreviations: BAPTA/AM, Bis-(O-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetra(acetoxymethyl)-ester; C-PAF, carbamyl-PAF; CSF, colony-stimulating factor; D-PBS, Dulbecco’s PBS; H-7, 1-(5-isoquinolinesulfonyl)-2-metylpiperazine; PAF, platelet-activating factor; PAF-AH, PAF-acetylhydrolase; PKC, protein kinase C; TPA, 12-O-tetradecanoylphobol 13-acetate.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society